Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis

医学 内科学 DLCO公司 荟萃分析 子群分析 科克伦图书馆 安慰剂 不利影响 特发性肺纤维化 肺功能测试 随机对照试验 中医药 肺功能 扩散能力 病理 替代医学
作者
Kun Ji,MA Jian-ling,WANG Liangmin,Niuniu Li,Shangjuan Dong,Shi Li-qing
出处
期刊:Evidence-based Complementary and Alternative Medicine [Hindawi Publishing Corporation]
卷期号:2020: 1-11 被引量:15
标识
DOI:10.1155/2020/1752387
摘要

To evaluate the efficacy and safety of traditional Chinese medicine (TCM) on lung function and quality of life of idiopathic pulmonary fibrosis (IPF) patients by meta-analysis.Randomized controlled trials (RCTs) related to TCM and IPF were searched on PubMed, EMBASE Cochrane Library, ClinicalTrials, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chin VIP Information (VIP), and Chinese Biomedical Database (CBM) until December 2018. Standard mean difference (SMD) and 95% CI were calculated for the measurements related to lung function (FEV1/FVC, FVC%, FEV1%, TLC%, DLCO% or DLCO, and VC%) and other parameters (PO2, 6MWD, and SGRQ) when comparing TCM treatment to the control group. Relative risk (RR) and 95% CI of adverse events (AEs) were calculated to assess the safety of TCM.A total of 40 RCTs comparing TCM to western medicine (WM) and involving 3194 IPF patients were eligible for the meta-analysis. The pooled results showed that TCM treatment improved significantly PO2 (SMD = 0.80, 95% CI 0.54 to 1.06, p < 0.001), FEV1% (SMD = 0.57, 95% CI 0.42 to 0.71, p < 0.001), DLCO% (SMD = 0.38, 95% CI 0.28 to 0.48, p < 0.001), 6MWD (SMD = 0.70, 95% CI 0.56 to 0.84, p < 0.001) and other measurements and reduced SGRQ scores (SMD = −0.51, 95% CI −0.70 to −0.22, p < 0.001). Subgroup analysis of different study durations (3 months, ≥ 6 months) and comparison models (TCM vs. WM, TCM + WM vs. WM or TCM vs. placebo) showed similar results. No significant difference of risk of AEs was observed between both groups (RR = 0.66, 95% CI: 0.27–1.60, p=0.352). There was no obvious publication bias, and the pooled results were stable according to sensitivity analysis.To the best of our knowledge, the present study had the largest sample size. Our results indicated that TCM treatment may help provide benefit to the lung function, exercise capacity, and quality of life of IPF patients, alone or combined with WM, when compared to WM. More rigorous RCTs were needed in the future.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
大鹅莓烦恼完成签到,获得积分10
1秒前
Zzz呀完成签到 ,获得积分10
1秒前
abtitw完成签到,获得积分10
2秒前
wyuwqhjp完成签到,获得积分10
2秒前
pingbaby发布了新的文献求助10
2秒前
云在天涯发布了新的文献求助10
3秒前
优秀念柏完成签到,获得积分10
3秒前
sagitar完成签到,获得积分0
4秒前
samchen完成签到,获得积分10
6秒前
chenzhuod完成签到,获得积分10
6秒前
7秒前
zrrr完成签到 ,获得积分10
8秒前
日照金峰完成签到,获得积分10
8秒前
yyy1234567完成签到,获得积分10
9秒前
单纯的乐曲完成签到,获得积分10
10秒前
桃花岛主完成签到,获得积分10
10秒前
徐先生完成签到,获得积分10
12秒前
Loretta完成签到 ,获得积分10
13秒前
加一点荒谬完成签到,获得积分10
13秒前
xinL完成签到,获得积分10
13秒前
老实的黑米完成签到 ,获得积分10
13秒前
Crssss完成签到 ,获得积分10
14秒前
小于子88完成签到,获得积分10
14秒前
elsa嘻嘻完成签到 ,获得积分10
16秒前
濮阳冰海完成签到 ,获得积分10
16秒前
rainny完成签到,获得积分10
19秒前
小红完成签到,获得积分10
19秒前
JiaoJiao完成签到,获得积分20
19秒前
怡然新之完成签到 ,获得积分10
21秒前
EE5577发布了新的文献求助10
22秒前
霸王爱吃面完成签到,获得积分10
23秒前
xlj发布了新的文献求助10
25秒前
淡淡依霜完成签到 ,获得积分10
26秒前
123456完成签到 ,获得积分10
27秒前
WaterBru完成签到,获得积分10
27秒前
vanliu完成签到,获得积分10
28秒前
研友_LX7zK8完成签到,获得积分10
28秒前
苏信怜完成签到,获得积分10
30秒前
Snail6完成签到,获得积分10
31秒前
mhy完成签到 ,获得积分10
34秒前
高分求助中
Clinical Epidemiology: The Essentials, 6e 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Graphene Handbook (2019 Edition) 800
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
久松真一著作集〈第5巻〉禅と芸術 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6554899
求助须知:如何正确求助?哪些是违规求助? 8339335
关于积分的说明 17865415
捐赠科研通 5672111
什么是DOI,文献DOI怎么找? 2940121
邀请新用户注册赠送积分活动 1915984
关于科研通互助平台的介绍 1785755